Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Sana Biotechnology, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $26.25M | $26.25M - $26.25M | $0.00 | -$0.623 | 2 |
| Dec 2029 | $4.97M | $4.97M - $4.97M | $0.00 | -$0.68 | 2 |
| Dec 2028 | $19.80M | $19.80M - $19.80M | $0.00 | -$0.592 | 5 |
| Dec 2027 | $6.95M | $6.95M - $6.95M | $0.00 | -$0.577 | 6 |
| Dec 2026 | $0.00 | $0.00 - $0.00 | $0.00 | -$0.612 | 0 |
| Dec 2025 | $0.00 | $0.00 - $0.00 | $0.00 | -$0.863 | 0 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.186 | 0 |